Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
- Published In:
- The New England journal of medicine, 393(7), 635-647 (2025)
- Authors:
- Garvey, W Timothy(4), Blüher, Matthias(4), Osorto Contreras, Cynthia Karenina, Davies, Melanie J, Winning Lehmann, Eva, Pietiläinen, Kirsi H, Rubino, Domenica, Sbraccia, Paolo, Wadden, Thomas, Zeuthen, Niels, Wilding, John P H
- Database ID:
- RPEP-11062
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11062APA
Garvey, W Timothy; Blüher, Matthias; Osorto Contreras, Cynthia Karenina; Davies, Melanie J; Winning Lehmann, Eva; Pietiläinen, Kirsi H; Rubino, Domenica; Sbraccia, Paolo; Wadden, Thomas; Zeuthen, Niels; Wilding, John P H. (2025). Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.. The New England journal of medicine, 393(7), 635-647. https://doi.org/10.1056/NEJMoa2502081
MLA
Garvey, W Timothy, et al. "Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.." The New England journal of medicine, 2025. https://doi.org/10.1056/NEJMoa2502081
RethinkPeptides
RethinkPeptides Research Database. "Coadministered Cagrilintide and Semaglutide in Adults with O..." RPEP-11062. Retrieved from https://rethinkpeptides.com/research/garvey-2025-coadministered-cagrilintide-and-semaglutide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.